Show Notes

The Commons host, Thomas Osha, catches up with serial entrepreneur, Steve Potts, to discuss his latest venture, SLAM BioTherapeutics.  Slam Bio is developing a platform of first-in-class monoclonal antibody therapies and antibody-drug conjugates (ADCs) targeting cancer, beginning with blood cancers.

The conversation took place at the BIO International Conference 2024 in San Diego June 4-6, 2024.

slambio.com